share_log

On April 3, Iterum Therapeutics Received Letter From Nasdaq Indicating That It Is Not In Compliance With Nasdaq Listing Rule

On April 3, Iterum Therapeutics Received Letter From Nasdaq Indicating That It Is Not In Compliance With Nasdaq Listing Rule

4月3日,Iterum Therapeutics收到纳斯达克的来信,表示其不符合纳斯达克上市规则
Benzinga ·  04/05 16:36

On April 3, Iterum Therapeutics Received Letter From Nasdaq Indicating That It Is Not In Compliance With Nasdaq Listing Rule

4月3日,Iterum Therapeutics收到纳斯达克的来信,表示其不符合纳斯达克上市规则

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发